GSK: Iain Mackay
GSK has announced that it will appoint Iain Mackay as its new chief financial officer. Mackay will arrive to the company from outside of the pharmaceutical industry, having worked as CFO for HSBC for the last 11 years. However, he had previously worked for three years at soon-to-be independent GE Healthcare.
Emma Walmsley, CEO of GSK said of the appointment: “I’m delighted to welcome Iain to GSK. As a proven CFO of a complex, regulated global organisation, he brings tremendous finance experience and will be a great addition to the team. He is a strong leader with a track record of driving cost, cash and capital allocation discipline to deliver strategy. These capabilities will be vital as we continue to implement our Innovation, Performance and Trust priorities for the benefit of patients and shareholders.”
Mackay will begin working at GSK on January 14, 2019, replacing the outgoing CFO, Simon Dingemans, who will retire from the company in May 2019. Mackay had been identified as a replacement after Dingemans made the announcement he would retire in May 2018. Dingemans had performed the role of CFO from 2011.
At the time, Dingemans explained his decision to leave after eight years in a company statement: “It has been a privilege to be part of GSK and to have had the opportunity as CFO to lead many key initiatives to drive the company forward and make it fitter for the future. With the new strategy set, we have established strong foundations to deliver improved business and financial performance and I believe now is the right time for me to take this decision.”